Free Trial

Wilmington Savings Fund Society FSB Sells 3,645 Shares of Maximus, Inc. $MMS

Maximus logo with Business Services background

Key Points

  • Wilmington Savings Fund Society FSB reduced its stake in Maximus, Inc. by 5.8%, selling 3,645 shares and retaining approximately 59,284 shares valued at $4,162,000.
  • Maximus reported strong quarterly earnings with an EPS of $2.16, exceeding analyst expectations of $1.39, and highlighted a revenue growth of 2.5% year-over-year.
  • The company announced a quarterly dividend of $0.30 per share, set to be paid on December 1st, with investors of record on November 14th.
  • MarketBeat previews the top five stocks to own by November 1st.

Wilmington Savings Fund Society FSB lessened its holdings in Maximus, Inc. (NYSE:MMS - Free Report) by 5.8% during the second quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 59,284 shares of the health services provider's stock after selling 3,645 shares during the period. Wilmington Savings Fund Society FSB owned about 0.11% of Maximus worth $4,162,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also recently bought and sold shares of MMS. GAMMA Investing LLC grew its position in Maximus by 67.1% in the first quarter. GAMMA Investing LLC now owns 732 shares of the health services provider's stock valued at $50,000 after acquiring an additional 294 shares during the last quarter. Exchange Traded Concepts LLC bought a new stake in shares of Maximus during the first quarter worth about $794,000. Janney Montgomery Scott LLC grew its holdings in shares of Maximus by 70.5% during the first quarter. Janney Montgomery Scott LLC now owns 10,145 shares of the health services provider's stock worth $692,000 after purchasing an additional 4,196 shares during the last quarter. QRG Capital Management Inc. grew its holdings in shares of Maximus by 25.9% during the first quarter. QRG Capital Management Inc. now owns 6,286 shares of the health services provider's stock worth $429,000 after purchasing an additional 1,293 shares during the last quarter. Finally, Global Trust Asset Management LLC bought a new stake in shares of Maximus during the first quarter worth about $155,000. Institutional investors own 97.21% of the company's stock.

Insider Activity at Maximus

In related news, insider Michelle F. Link sold 1,610 shares of Maximus stock in a transaction that occurred on Wednesday, October 1st. The stock was sold at an average price of $90.86, for a total value of $146,284.60. Following the transaction, the insider directly owned 13,508 shares of the company's stock, valued at $1,227,336.88. The trade was a 10.65% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. 1.60% of the stock is currently owned by corporate insiders.

Maximus Price Performance

Maximus stock opened at $84.76 on Wednesday. The stock's 50 day moving average is $87.09 and its 200 day moving average is $76.39. The company has a debt-to-equity ratio of 0.91, a current ratio of 2.27 and a quick ratio of 2.27. The firm has a market cap of $4.78 billion, a P/E ratio of 15.61 and a beta of 0.57. Maximus, Inc. has a one year low of $63.77 and a one year high of $93.73.

Maximus (NYSE:MMS - Get Free Report) last posted its quarterly earnings data on Thursday, August 7th. The health services provider reported $2.16 EPS for the quarter, topping analysts' consensus estimates of $1.39 by $0.77. The company had revenue of $1.35 billion for the quarter, compared to analyst estimates of $1.29 billion. Maximus had a return on equity of 24.44% and a net margin of 5.83%.The firm's quarterly revenue was up 2.5% on a year-over-year basis. During the same period in the previous year, the firm earned $1.74 earnings per share. Maximus has set its FY 2025 guidance at 7.350-7.550 EPS. As a group, research analysts expect that Maximus, Inc. will post 6.15 EPS for the current year.

Maximus Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Monday, December 1st. Investors of record on Friday, November 14th will be paid a $0.30 dividend. This represents a $1.20 dividend on an annualized basis and a dividend yield of 1.4%. The ex-dividend date of this dividend is Friday, November 14th. Maximus's payout ratio is currently 22.10%.

Wall Street Analysts Forecast Growth

Several analysts have recently weighed in on MMS shares. Zacks Research upgraded Maximus from a "hold" rating to a "strong-buy" rating in a report on Tuesday, August 26th. Weiss Ratings upgraded Maximus from a "hold (c+)" rating to a "buy (b-)" rating in a report on Wednesday, October 8th. One investment analyst has rated the stock with a Strong Buy rating and two have assigned a Buy rating to the company's stock. Based on data from MarketBeat, the company has a consensus rating of "Buy" and an average price target of $90.00.

Check Out Our Latest Research Report on MMS

Maximus Profile

(Free Report)

Maximus, Inc operates as a provider of government services in the United States and internationally. It operates through three segments: U.S. Federal Services, U.S. Services, and Outside the U.S. The U.S. Services segment offers program eligibility support and enrollment; centralized multilingual customer contact centers, multichannel, and digital self-service options for enrollment; application assistance and independent health plan choice counseling; beneficiary outreach, education, eligibility, enrollment, and redeterminations; and person-centered independent disability, long-term sick, and other health assessments.

Featured Stories

Want to see what other hedge funds are holding MMS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Maximus, Inc. (NYSE:MMS - Free Report).

Institutional Ownership by Quarter for Maximus (NYSE:MMS)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Maximus Right Now?

Before you consider Maximus, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Maximus wasn't on the list.

While Maximus currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Ten Starter Stocks For Beginners to Buy Now Cover

Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.

Get This Free Report
Like this article? Share it with a colleague.